Used to be a GOOD THING then PHARMA CAME AND CALLED IT SNAKE OIL

OldMedUser

OldMedUser

Well-Known Member
gb123 said:
never blamed docs eh..theyre just pawns that are told what can be done is all.
and where to push the work! ;)
Click to expand...
So true and with Big Pharma financing most of the medical schools they are all just legal drug pushers in clean white coats.

Even mention using an alternative to what they are pushing and they look at you like you have two heads. They get about a week of training how nutrition affects health. The last three physicals I've had in the last 6 years or so not one doc has had me take any clothes off or do a digital rectal exam until recently when we had a young female doc here for a month that did that. Much nicer than some hairy guy from South Africa where all the docs we have come from. :)

This nurse practitioner the wife and I are seeing now sent me for blood tests for all my minerals. inflammation and some other stuff to get to the root of these "nap attacks" I've been having for years. If I can get a diagnosis with a name I can re-apply for my provincial disability and get back pay for the four years since they denied my appeal. That would be sweet! $750/mth from CPP-D is just not enough.

I've been afraid to really bitch about it for fear they'll pull my Class 1 license or even forbid me from driving altogether. It's not like narcolepsy but a slow drain of energy until I'm damn near comatose for an hour then cranky and miserable for a couple more hours, Full of energy after and up all night.

Fingers crossed and I'll be seeing her early in the new year for the results.

:peace:
 
G

gb123

Well-Known Member

Big pharma snub, placebo snag to blame for lack of medical pot research: experts


VANCOUVER — A disinterested pharmaceutical industry and the conundrum of finding a convincing placebo are just two reasons experts say there has been little quality research into medicinal marijuana.

A growing number of Canadians are turning to medical cannabis despite questions about its risks and effectiveness as a health product.

Marijuana's unconventional journey onto the medical market puts it at odds with more mainstream medications, which typically undergo years of costly scrutiny before being approved for use, said Mark Ware, a pain researcher at McGill University Health Centre in Montreal.

Ware said pharmaceutical companies are willing to pay hundreds of millions of dollars for clinical trials because once a drug is approved they have a window of time to sell it exclusively.

"When you think about medications that have been given approval to be sold in pharmacies, that's where most if not all of our medications come from," he said.

"That model simply does not hold for much of the classical herbal cannabis research, where you're looking for basic claims of efficacy and safety, but not trying to make a formal claim for a product that is going to be patented."

Ware, who also served as vice-chair on the federal government's task force on legalizing cannabis, said competition among licensed marijuana producers is leading some of them to funnel money toward research in an effort to differentiate their brand from others.

But Dr. Mike Allan, a professor of family medicine at the University of Alberta in Edmonton, said there are few benefits for producers to conduct the research.

"It's already at market so there's really no incentive, or virtually no incentive, for licensed producers to take the money they're generating from the sale of these products and reinvest it in research," Allan said.

While a positive outcome might not have much of an effect on the industry's bottom line, a negative outcome could seriously harm profits, he added.

Data from Health Canada show the number of clients registered with licensed medicinal cannabis producers jumped between June 2016 and June 2017, from 75,166 to more than 200,000. Registrations more than tripled in each of the two previous years.

University of Saskatchewan professor, Robert Laprairie, said the absence of the pharmaceutical industry means medical marijuana research is being done for the benefit of the patient.

"We're in a unique place because a lot of large pharmaceutical companies are reluctant to fund these studies where they don't necessarily see the incentive for something that they aren't able to patent," said Laprairie, who conducts cannabinoid research at the university.

Laprairie said he has seen a heavy push in recent months from academics, patients and licensed producers for more medical cannabis research.

But Dr. Meldon Kahan of the Women's College Hospital in Toronto, said this kind of research, sponsored by licensed producers, is still problematic.

"You can design a short-term study with marijuana, or for that matter, with alcohol or opiates, and say, 'Look, we gave people a bunch of alcohol over a three-day period or one week or one month and they seem to feel better. It helped their anxiety.' But that doesn't mean it's a good medication," he said.

Kahan said there does appear to be some evidence that cannabidiol, a compound in marijuana, does have some medical benefits, including pain relief, but more study is needed.

Ware said another dilemma in conducting research on medical marijuana is the absence of a plausible placebo, especially because study participants often have experience using cannabis and recognize if they have been placed in the study or control group.

"Access to a credible placebo may seem like an odd thing to have as a challenge," Ware said.

"But bear in mind that many of these studies are placebo-controlled, so you need a drug which is a credible placebo — looks and smells and for all intents and purposes pretends it is cannabis when in fact it does not have the active ingredient you are testing."

Allan cited a study that found between 85 and 90 per cent of nurses could tell when patients were on pills derived from cannabis.
 
WHATFG

WHATFG

Well-Known Member
So no competent placebo eh?....kind of interesting that this is a stumbling block....something that hasn't killed anyone and they can't find a way to make it safer because they can't find a fake way to feed you....hasn't the last umpteen years been a giant experiment? Seriously, millions of fucking people can't be wrong.
 
VIANARCHRIS

VIANARCHRIS

Well-Known Member
gb123 said:
"But bear in mind that many of these studies are placebo-controlled, so you need a drug which is a credible placebo — looks and smells and for all intents and purposes pretends it is cannabis when in fact it does not have the active ingredient you are testing."
Click to expand...
Cannabis edibles and placebo's is one option - so is pill form Or how about this secret study technique:
Patient A and Patient B both have arthritis pain. Patient A uses cannabis while Patient B does not. If Patient A got relief, then we can assume it was effective. Patient B who is still hurting did not get relief from not using cannabis. We then give Patient B some cannabis and see if his pain is reduced by it. If it was, one can safely assume cannabis helps with arthritis pain. How fucking hard was that? lol :bigjoint:
 
G

gb123

Well-Known Member
theyre next ;)

no one controls the peoples plant...not even hemp!
stuff way to valuable and they know it but just don't wanna say it out loud!



KirkTousaw‏Verified account@KirkTousaw
The biggest issue IMO is trying to push cannabis into a pathway designed for single compound pharmaceuticals. It’s a bad fit. That said there is a ton of evidence of medical efficacy already (including thousands of years of similar medical usage).
 
Last edited:
You must log in or register to reply here.
Top